Acasti Pharma (ACST) Reports Q2 Loss of $0.11
Tweet
Share
E-mailGet Alerts ACST Hot Sheet
Join SI Premium – FREE
Acasti Pharma (NASDAQ: ACST) reported Q2 EPS of ($0.11).
For earnings history and earnings-related data on Acasti Pharma (ACST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
- zSpace, Inc. (ZSPC) Reports Q2 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
